PMPRB Summary of VCUs & Orders - 2006

Click on medicine to view details of VCU

DATE OF APPROVAL MEDICINE PATENTEE %Above Guidelines PRICE REDUCTION1 EXCESS REVENUES2 PAYMENTS PATENT STATUS
VCUs
July 14, 2006 Eloxatin sanofi-aventis Canada Inc. Yes $1,767,078.84 $1,767,078.846 Expiration 06/2019
July 14, 2006 Hextend Hospira Healthcare Corporation (Canada) 40 Yes $8,823.60 $8,823.60 Expiration 06/2014
June 20, 2006 NuvaRing Organon Canada Ltd Yes Yes $115,584.93 $115,584.93 Expiration 03/2018
Apr. 8, 2006 DukoralTM sanofi pasteur Limited Yes $74,073.32 7 $74,073.32 Expiration 06/2016
ORDER

1.There are no price reductions in cases where the PMPRB's jurisdiction ceased with the expiry or the dedication (prior to 1995) of the patent.

2. In all cases, all excess revenues were offset through further price reduction and/or payment.

7. Excess revenues for the period of July 1 - December 31, 2005, as per the VCU of December 15, 2005.

Date modified: